Atara Biotherapeutics Inc — Quarterly Financial Statistics (NASDAQ:ATRA) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 3.99 M24.47 M28.14 M7.32 M9.79 M 69.71 M Cash from investing activities -16.66 M3.38 M17.2 M-5.07 M-2.42 M 13.08 M Cash from financing activities 35.79 M-328 K250 K14.8 M1.05 M 15.77 M Free cash flow 3.99 M24.38 M28.14 M7.32 M9.79 M 69.62 M

Haberler

Atara 9 milyon dolarlık ödeme tarihini 2028’e erteledi

Atara extends $9M milestone payment deadline to 2028

Atara Bio yöneticisi Huang James 489 bin dolarlık hisse satışı gerçekleştirdi

Atara Bio director Huang James sells $489k in shares

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.17%

FDA, Atara’nın tabelecleucel başvurusunu beklenmedik bir kararla reddetti

FDA rejects Atara’s tabelecleucel application in surprise reversal

Atara Biotherapeutics stock plunges after FDA rejects cancer therapy

Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Atara Biotherapeutics (NASDAQ:ATRA), Day One Biopharmaceutical (NASDAQ:DAWN)

Why Is Atara Biotherapeutics Stock Sinking Monday? - Atara Biotherapeutics (NASDAQ:ATRA)

US Stocks Lower; Dow Tumbles Over 250 Points - Atara Biotherapeutics (NASDAQ:ATRA), Envirotech Vehicles (NASDAQ:EVTV)

Atara Biotherapeutics: An Empty Pipeline With Little Gas (NASDAQ:ATRA)